Stock Evaluator: Stryker Corporation (SYK)

554 followers

Stryker Corporation SYK

$325.14 -22.91 -6.58%
July 31, 2026 2:16:31 PM EST November 10, 2021 Volume: 2,810,444
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NYSE | DELAYED PRICE
SECTOR INDUSTRY
Health Care Health Care Equipment & Supplies

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

Commentary & Analysis


Financial Summary

Share Statistics SYK Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $133,424.9 $334.8 98%
Shares Out (Mil) 386.5 41.7 86%
Institutional Ownership 89.8% 77.3% 58%
Float (Mil) 347.6 34.7 82%
Beta 0.78 0.86 46%
Avg Daily Volume (000s) 2,165 266 83%
Price Change
(52-week)
(13.1%) 60.7% 35%
Growth SYK Industry
Median
Percentile
(All Stocks)
Sales (5yr) 11.8% 11.8% 65%
Net Income (5yr) 15.2% (5.8%) 63%
EPS (5yr) 14.9% 10.7% 55
Dividends (5yr) 7.6% 0.0% 95%
Cash Flow (5yr) 17.6% (16.1%) 77%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates 24 27 27
Current EPS $3.488 $14.973 $16.728
Month Ago EPS $3.488 $14.983 $16.724
# Rev Up 0 1 0
# Rev Down 1 1 0
Three Months Ago EPS $3.460 $14.962 $16.744
Year/Year Chg 80.7% 78.3% 121.3%
Financials SYK Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $25,270 $152 93%
Net Income (TTM) (Mil) $3,337 ($11) 95%
EPS (TTM) $8.724 ($0.500) 93%
Operating Cash Flow (TTM) (Mil) $5,375 ($2) 95%
Net Cash Flow (TTM) (Mil) $558 $1 92%
Long-Term Debt (Q1) (Mil) $14,574 $22 94%
Enterprise Value (Q1) (Mil) $134,895 $304 97%
Valuation SYK Industry
Median
Percentile
(All Stocks)
P/B 5.81 2.88 81%
P/E 40.3 30.5 79%
Dividend Yield 1.0% 0.0% 67%
PEG (5yr hist) 2.7 1.9 75%
Ratios SYK Industry
Median
Percentile
(All Stocks)
Gross Margin 64.7% 59.1% 77%
Net Margin 13.2% (7.7%) 70%
ROA 7.2% (13.7%) 80%
ROE 15.2% (15.9%) 72%
Liabilities to Assets 50.4% 44.9% 42%
F-Score 8 4 94%

Stryker Corporation did not pass any screens on 7/30/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors